Skip to main content
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. — Investor Relations & Filings

Ticker · CRBP ISIN · US21833P3010 LEI · 529900MX6XCNZC7MM155 US Manufacturing
Filings indexed 755 across all filing types
Latest filing 2026-04-14 Regulatory Filings
Country US United States of America
Listing US CRBP

About Corbus Pharmaceuticals Holdings, Inc.

https://www.corbuspharma.com/

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for oncology and obesity. The company's pipeline is centered on targeted therapies designed to address significant unmet medical needs and improve patient outcomes. Its lead oncology candidate, CRB-701, is an antibody-drug conjugate (ADC) in Phase 1/2 clinical development for treating solid tumors, including Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancer. Corbus is committed to advancing its programs through rigorous scientific research and a focus on enhancing quality of life for patients.

Recent filings

Filing Released Lang Actions
8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Regulatory Filings
2026-04-14 English
8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Regulatory Filings
2026-04-07 English
ARS - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Annual Report
2026-04-02 English
424B3 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Prospectus
2026-03-25 English
EFFECT - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Regulatory Filings
2026-03-23 English
4 - CORBUS PHARMACEUTICALS HOLDINGS, INC. (0001595097) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.